Current purchasing policy for health services in the UK and elsewhere requires that there is evidence for their effectiveness. The demonstration of effectiveness in rehabilitation is complicated by the problems of small numbers and heterogeneity in the study population, necessitating multicentre trials or meta-analyses to generate robust evidence. To date these have often been confounded by the absence of common language outcome measures. As regular reporting on clinical outcome becomes increasingly obligatory, this could serve to strengthen the evidence base, but only if we can agree on a common set of outcomes.
Whether resulting from stroke, trauma or other causes, brain injury poses a number of particular problems for outcome measurement. A slow rate of progress may mean several months in hospital and there is understandable pressure from purchasers to justify the substantial cost of rehabilitation. Many patients are undergoing treatment in the postacute phase of brain injury so that outcome from rehabilitation must be assessed against a background of spontaneous recovery. Cognitive and communicative problems not only impede progress in therapy, but are often the major factors limiting return to independence, and measures need to take account of these areas, as well as assessing physical disability. Finally, the level of disability is dependent on the environment in which it is assessed. If measurement of outcome is to be continued in the community, it is helpful to have a common core of data that can be followed through from hospital to community, even though more detailed measurements in the two settings may be different.
When selecting an outcome measure for any purpose, a common set of criteria apply. Measures must be valid and reliable, but they must also be relevant to the area of intervention and sensitive to the change occurring over the time scale for which treatment is given. There is an inverse relationship between reliability and sensitivity -the more sensitive an instrument is, the less reliable -and the more detailed an instrument, the more cumbersome it is to use, so compromise becomes inevitable. Measures must also be feasible to use in the course of routine practice; they should be easy to apply and timely to complete. It is also important that the team feel they have ownership of the results. If data are gathered and used effectively as an integral part of clinical practice, their relevance is clear and they are much more likely to be collected consistently.
Global measures of disability have gained in popularity over the last decade. They provide a broad overview of the individual's independence in a range of tasks and, by engaging different members of the multidisciplinary team in scoring, they facilitate team communication. Providing it is consistently applied, a generic measure also has the potential to form a common language and facilitate communication between different centres, providing opportunities for collaborative research. But this consistency is crucial. If different units rate the measure according to different rules, there is still no valid comparison.
A recent survey of rehabilitation units in the UK demonstrated that the Barthel Index (BI), the Functional Independence Measure (FIM) or the Functional Assessment Measure (FIM+FAM) were the most commonly used global measures of disability. 1 Indeed, 95% of the units who used a measure as part of routine clinical practice used one or more of these. Thus if common elements can be found, we already have brain injury, and still maintains the integrity of the FIM, providing the opportunity of comparison at that level, with units which score only the FIM.
Despite its disadvantages, the FIM+FAM has been adopted by a significant number of brain injury units around the world, and increasingly also in the UK. A UK FIM+FAM Users Group has recently developed a UK version of the FIM+FAM (see page 280) which may help to provide greater scoring accuracy for the more subjective items. The group has also developed a centralized system for data collation and for training and updating users to ensure consistency and facilitate the sharing of data. 9 Clearly there are many common features between these three scales. If we understand the interrelationship between them, it may still be possible for units to share the common core of data. The FIM+FAM maintains the integrity of the FIM, providing the opportunity of comparison at that level. Likewise, although the conversion is not straightforward, a formula has been developed for conversion of the FIM to the BI, and derived scores are shown to agree with those rated directly. 10 Therefore, these three scales may be said to represent a spectrum from the simple to the complex, with a basic core of data at the level of the Barthel which may serve as a simple common language in disability measurement.
Some clinicians feel wary of centralized data collection and the opportunities for outside agencies to mishandle data for nonclinical agendas. Finance-orientated handling of FIM data has been one of the main factors to deter its wider use in the UK. Measurement tools can be used to assess outcome, but should not be used to dictate or direct therapy. If we are to have a system for sharing data, the rules regarding ownership and confidentiality must be clearly defined.
Global measures of disability may be the appropriate tools to assess the outcome for rehabilitation where the goals are to achieve independence, but they are not appropriate for all patients or in all settings. Community rehabilitation programmes, for example, may be targeted more towards reducing handicap and increasing quality of life, for both patient and carer. At the more dependent end of the scale, intervention may be focused on reducing carer burden. So, the basis for a potential common language measure.
The Barthel Index (BI) 2 provides a useful spot indicator of the level of dependence, but as a measure of outcome it is relatively insensitive to change and has marked floor and ceiling effects. It does not directly address cognitive and psychosocial function. While it is much the most commonly used global measure in the UK, there are a number of different scoring manuals in use, so in current usage it cannot be said to be homogeneous.
The Functional Independence Measure (FIM) 3 is more extensive, and is very widely used as a global measure of disability in the USA. Its originators, Uniform Data Systems (UDS), have recognized the problem of consistent usage. They provide not only a centralized system of data collation, but also training and updating of users to ensure that the instrument is scored consistently wherever it is used. However, the FIM has failed to gain universal acclaim as an outcome measure for brain injury, partly because the centralized data collation system is orientated towards the healthcare system in the USA and does not translate easily into other cultures, and partly because the FIM is still dominated by physical disability and offers only crude assessment for cognitive and psychosocial disability.
The Functional Assessment Measure (FIM+FAM) was developed specifically for use in brain injury. 4 It does not stand alone, but adds 12 further items to the FIM which specifically address cognitive and psychosocial issues, while applying the same 7-level scoring system. The latter are inevitably more subjective and difficult to score, 5 and reliability is as yet uncertain. 6 Although the FIM+FAM is shown to be more sensitive to deficits in intellectual functioning, communication and behaviour than the Barthel Index, 7 it still has ceiling effects in comparison with some other scales (such as the Disability Rating Scale). 8 It is recommended that the FIM+FAM is scored by a multidisciplinary team. This offers the advantages of encouraging team communication and increased reliability, but makes it cumbersome for use in routine clinical practice. Nevertheless the FIM+FAM offers an opportunity to score psychosocial function following while it is useful to have a core dataset for comparative purposes, and global measures may give a useful indication of overall level of disability, this is not to suggest that they should be used to the exclusion of other tools more relevant to the area of intervention. Indeed, it is rarely the case that a single measure will suffice.
In conclusion
Outcome measurement in rehabilitation is a major area of development in which we can expect substantial change over the next decade. However, the concept of a basic common scale with add-on modules to suit different settings or address different areas of rehabilitation may be a way forward for the future which would ensure timely data collection, while focusing directly on the area(s) of intervention. While there is much to be gained from collation of data, careful thought must be given to safeguarding the use and ownership of common data, to ensure that it is interpreted in context and used to the advantage, and not to the disadvantage, of this vulnerable group of patients.
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